Old Web
English
Sign In
Acemap
>
Paper
>
Third-Party Mesenchymal Stromal Cell Therapy and Risk of Allosensitisation in Transplant Patients
Third-Party Mesenchymal Stromal Cell Therapy and Risk of Allosensitisation in Transplant Patients
2017
Srikanth Reddy
Georgios Vrakas
Mian Chen
Martin Barnardo
Philip Allan
Franscesco Dazzi
Peter J. Friend
Susan V. Fuggle
Keywords:
Immunology
Mesenchymal stem cell
Stromal cell
Medicine
Oncology
transplant patient
third party
Internal medicine
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]